| Literature DB >> 31793757 |
Hui Zhou1,2,3, Wanrong Yi4, Anguo Li2, Bo Wang1, Qihang Ding2, Liru Xue1, Xiaodong Zeng2,3, Yanzhi Feng1, Qianqian Li2,3, Tian Wang1, Yang Li2, Xiaoding Cheng2, Lin Tang2, Zixin Deng2, Mingfu Wu1, Yuling Xiao2,3, Xuechuan Hong2,3.
Abstract
Osteosarcoma is an aggressive tumor of mesenchymal origin that is more likely to spread to the lung than others, with a major impact on patients' prognosis. The optimal imaging method that can reliably detect or exclude pulmonary metastases from osteosarcoma is still scarce. Herein, two homologous types of fluorescent probes CH1055-PEG-PT and CH1055-PEG-Affibody, which show highly promising results for targeting imaging of osteosarcoma and its lung metastasis, respectively, are designed and synthesized. It is found that the NIR-II imaging quality of CH1055-PEG-PT is far superior to that of computed tomography for the early in vivo 143B tumor imaging, and this probe-guided surgery for accurate resection of 143B tumor is further performed. The high-resolution visualization of primary and micrometastatic lung lesions of osteosarcoma by using CH1055-PEG-Affibody is also demonstrated. Therefore, the attractive imaging properties of CH1055-PEG-PT and CH1055-PEG-Affibody, including high levels of uptakes, and high spatial and temporal resolution, open up opportunities for molecular imaging and clinical translation of osteosarcoma and its lung metastasis in the unique second near-infrared window.Entities:
Keywords: NIR-II fluorescence imaging; lung metastasis; osteosarcoma
Mesh:
Substances:
Year: 2019 PMID: 31793757 DOI: 10.1002/adhm.201901224
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933